Now in Effect: Maryland Right to Try Act Rejects Some FDA Restrictions on Terminal Patients

ANNAPOLIS, Md. (Oct 2, 2017) – Yesterday, a Maryland law went into effect that sets the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients. Del. Karen Young (D-Frederick) sponsored House Bill 584 (HB584) along with 18 bipartisan co-sponsors. The new law…

Continue ReadingNow in Effect: Maryland Right to Try Act Rejects Some FDA Restrictions on Terminal Patients

Signed By the Governor: Maryland Right to Try Act Rejects Some FDA Restrictions on Terminal Patients

ANNAPOLIS, Md. (June 2, 2017) – Last week, Maryland Gov. Larry Hogan signed a bill  into law that sets the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients. Del. Karen Young (D-Frederick) sponsored House Bill 584 (HB584) along with 18 bipartisan…

Continue ReadingSigned By the Governor: Maryland Right to Try Act Rejects Some FDA Restrictions on Terminal Patients

To the Governor: Maryland House Approves Right to Try Act to Reject Some FDA Restrictions on Terminal Patients

ANNAPOLIS, Md. (April 10, 2017) – Today, the Maryland House gave final approval to a bill that would set the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients. Introduced by Del. Karen Young (D-Frederick) and 18 bipartisan co-sponsors, House Bill 584…

Continue ReadingTo the Governor: Maryland House Approves Right to Try Act to Reject Some FDA Restrictions on Terminal Patients

Maryland House Passes Right to Try Act to Reject Some FDA Restrictions on Terminal Patients

ANNAPOLIS, Md. (March 21, 2017) – Yesterday, the Maryland House unanimously passed a bill that would set the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients. Introduced by Del. Karen Young (D-Frederick) and 18 bipartisan co-sponsors, House Bill 584 (HB584) would…

Continue ReadingMaryland House Passes Right to Try Act to Reject Some FDA Restrictions on Terminal Patients

Maryland Bill Would Defy FDA, Allow Experimental Treatments for Terminally-Ill

ANNAPOLIS, Md. (Feb. 6, 2017) – A bill introduced in the Maryland House would the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients. Introduced by Del. Karen Young (D-Frederick) and 18 bipartisan co-sponsors, House Bill 584 (HB584) would give terminally ill…

Continue ReadingMaryland Bill Would Defy FDA, Allow Experimental Treatments for Terminally-Ill